lncRNA TOPORS-AS1 as a Biomarker for Ovarian Cancer Prognosis and Potential Treatment Target
Investigating biomarkers for prediction of outcome and treatment of clinical and pathological features of breast and ovarian cancers
Published: 4th June 2021

IP Status
- No patent
- Know-how based
Seeking
- Development partner
- Commercial partner
- Seeking investment